Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Woman reading the article on multiparametric MRI in prostate cancer treatments on her laptop

Use of Multiparametric MRI in Prostate Cancer Treatments: A Prospective Study

The prospective study conducted by LMU Klinikum München investigates the effectiveness of vascular-targeted photodynamic therapy (VTP) and high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer.

Using multiparametric MRI (mpMRI), ten patients were monitored over the course of one year to track anatomical changes and potential tumor recurrence.

The results show that mpMRI reliably captures changes in prostate and tumor volumes, with an initial increase in prostate volume, followed by a significant reduction after one year. A recurrence was detected in one patient.

mpMRI proves to be a valuable tool for monitoring tumor recurrence, but further validation in larger studies is required.

Read more about the study here.

Related Resources

Related Resources

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients…

RECIST measurements of a patient with uveal melanoma and hepatic metastases

University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…

A picture of workshop participants  next to a positive review for the ESOI-EORTC RECIST Workshop in Munich

ESOI-EORTC Workshop on Imaging in Assessing Response to Cancer Therapy - A Participant's Perspective

Following the conclusion of the ESOI-EORTC Workshop on Imaging in Assessing Response to Cancer Therapy in Munich, we were keen to gather feedback…